Cardiologists are struggling to figure out why a drug that should have prevented heart attacks didn’t work at all.

Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.

The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart disease.

The new pills can lower cholesterol levels far below what can be achieved with statins, clinical trials have shown.

Her decades of work on Huntington’s disease helped lead to the creation of a genetic test for the devastating condition. Why didn’t she take it herself?

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.